{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T03:09:40Z","timestamp":1768705780440,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T00:00:00Z","timestamp":1431993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Mol Morphol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00795-015-0107-2","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T06:43:51Z","timestamp":1431931431000},"page":"123-128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Double heterozygous mice for Klf5 and Fli1 genes: a new animal model of systemic sclerosis recapitulating its three cardinal pathological features"],"prefix":"10.1007","volume":"48","author":[{"given":"Yoshihide","family":"Asano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,19]]},"reference":[{"key":"107_CR1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1346-8138.2009.00758.x","volume":"37","author":"Y Asano","year":"2010","unstructured":"Asano Y (2010) Future treatments in systemic sclerosis. J Dermatol 37:54\u201370","journal-title":"J Dermatol"},{"key":"107_CR2","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/ncomms6797","volume":"5","author":"S Noda","year":"2014","unstructured":"Noda S, Asano Y, Nishimura S, Taniguchi T, Fujiu K, Manabe I, Nakamura K, Yamashita T, Saigusa R, Akamata K, Takahashi T, Ichimura Y, Toyama T, Tsuruta D, Trojanowska M, Nagai R, Sato S (2014) Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis. Nat Commun 5:5797","journal-title":"Nat Commun"},{"key":"107_CR3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1346-8138.2009.00764.x","volume":"37","author":"T Yamamoto","year":"2010","unstructured":"Yamamoto T (2010) Animal model of systemic sclerosis. J Dermatol 37:26\u201341","journal-title":"J Dermatol"},{"key":"107_CR4","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1002\/art.27647","volume":"62","author":"C Beyer","year":"2010","unstructured":"Beyer C, Schett G, Distler O, Distler JH (2010) Animal models of systemic sclerosis: prospects and limitations. Arthritis Rheum 62:2831\u20132844","journal-title":"Arthritis Rheum"},{"key":"107_CR5","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","volume":"182","author":"A Servettaz","year":"2009","unstructured":"Servettaz A, Goulvestre C, Kavian N, Nicco C, Guilpain P, Ch\u00e9reau C, Vuiblet V, Guillevin L, Mouthon L, Weill B, Batteux F (2009) Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse. J Immunol 182:5855\u20135864","journal-title":"J Immunol"},{"key":"107_CR6","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1002\/art.30539","volume":"63","author":"A Yoshizaki","year":"2011","unstructured":"Yoshizaki A, Yanaba K, Ogawa A, Asano Y, Kadono T, Sato S (2011) Immunization with DNA topoisomerase I and Freund\u2019s complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling. Arthritis Rheum 63:3575\u20133585","journal-title":"Arthritis Rheum"},{"key":"107_CR7","doi-asserted-by":"crossref","first-page":"R194","DOI":"10.1186\/ar4028","volume":"14","author":"L Stawski","year":"2012","unstructured":"Stawski L, Han R, Bujor AM, Trojanowska M (2012) Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosis. Arthritis Res Ther 14:R194","journal-title":"Arthritis Res Ther"},{"key":"107_CR8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11926-008-0030-9","volume":"10","author":"M Wu","year":"2008","unstructured":"Wu M, Varga J (2008) In perspective: murine models of scleroderma. Curr Rheumatol Rep 10:173\u2013182","journal-title":"Curr Rheumatol Rep"},{"key":"107_CR9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1101\/gr.6.4.300","volume":"6","author":"LD Siracusa","year":"1996","unstructured":"Siracusa LD, McGrath R, Ma Q, Moskow JJ, Manne J, Christner PJ, Buchberg AM, Jimenez SA (1996) A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res 6:300\u2013313","journal-title":"Genome Res"},{"key":"107_CR10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/1523-1747.ep12535041","volume":"74","author":"DN Menton","year":"1980","unstructured":"Menton DN, Hess RA (1980) The ultrastructure of collagen in the dermis of tight-skin (Tsk) mutant mice. J Invest Dermatol 74:139\u2013147","journal-title":"J Invest Dermatol"},{"key":"107_CR11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/art.1780340512","volume":"34","author":"MH Bocchieri","year":"1991","unstructured":"Bocchieri MH, Henriksen PD, Kasturi KN, Muryoi T, Bona CA, Jimenez SA (1991) Evidence for autoimmunity in the tight skin mouse model of systemic sclerosis. Arthritis Rheum 34:599\u2013605","journal-title":"Arthritis Rheum"},{"key":"107_CR12","first-page":"680","volume":"123","author":"SV Szapiel","year":"1981","unstructured":"Szapiel SV, Fulmer JD, Hunninghake GW, Elson NA, Kawanami O, Ferrans VJ, Crystal RG (1981) Hereditary emphysema in the tight-skin (Tsk\/+) mouse. Am Rev Respir Dis 123:680\u2013685","journal-title":"Am Rev Respir Dis"},{"key":"107_CR13","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/art.20225","volume":"50","author":"J Pannu","year":"2004","unstructured":"Pannu J, Gore-Hyer E, Yamanaka M, Smith EA, Rubinchik S, Dong JY, Jablonska S, Blaszczyk M, Trojanowska M (2004) An increased transforming growth factor \u03b2 receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor \u03b2 receptor type II in scleroderma. Arthritis Rheum 50:1566\u20131577","journal-title":"Arthritis Rheum"},{"key":"107_CR14","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1002\/art.22063","volume":"54","author":"J Pannu","year":"2006","unstructured":"Pannu J, Gardner H, Shearstone JR, Smith E, Trojanowska M (2006) Increased levels of transforming growth factor \u03b2 receptor type I and up-regulation of matrix gene program: a model of scleroderma. Arthritis Rheum 54:3011\u20133021","journal-title":"Arthritis Rheum"},{"key":"107_CR15","doi-asserted-by":"crossref","first-page":"10405","DOI":"10.1074\/jbc.M611742200","volume":"282","author":"J Pannu","year":"2007","unstructured":"Pannu J, Nakerakanti S, Smith E, ten Dijke P, Trojanowska M (2007) Transforming growth factor-\u03b2 receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1\/2 pathways. J Biol Chem 282:10405\u201310413","journal-title":"J Biol Chem"},{"key":"107_CR16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/art.22328","volume":"56","author":"S Sonnylal","year":"2007","unstructured":"Sonnylal S, Denton CP, Zheng B, Keene DR, He R, Adams HP, Vanpelt CS, Geng YJ, Deng JM, Behringer RR, de Crombrugghe B (2007) Postnatal induction of transforming growth factor \u03b2 signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma. Arthritis Rheum 56:334\u2013344","journal-title":"Arthritis Rheum"},{"key":"107_CR17","doi-asserted-by":"crossref","first-page":"25109","DOI":"10.1074\/jbc.M300636200","volume":"278","author":"CP Denton","year":"2003","unstructured":"Denton CP, Zheng B, Evans LA, Shi-wen X, Ong VH, Fisher I, Lazaridis K, Abraham DJ, Black CM, de Crombrugghe B (2003) Fibroblast-specific expression of a kinase-deficient type II transforming growth factor \u03b2 (TGF\u03b2) receptor leads to paradoxical activation of TGF\u03b2 signaling pathways with fibrosis in transgenic mice. J Biol Chem 278:25109\u201325119","journal-title":"J Biol Chem"},{"key":"107_CR18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2741\/s22","volume":"1","author":"J Varga","year":"2009","unstructured":"Varga J, Whitfield ML (2009) Transforming growth factor-\u03b2 in systemic sclerosis (scleroderma). Front Biosci (Schol Ed) 1:226\u2013235","journal-title":"Front Biosci (Schol Ed)"},{"key":"107_CR19","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1073\/pnas.0801414105","volume":"105","author":"R Eferl","year":"2008","unstructured":"Eferl R, Hasselblatt P, Rath M, Popper H, Zenz R, Komnenovic V, Idarraga MH, Kenner L, Wagner EF (2008) Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2\/AP-1. Proc Natl Acad Sci USA 105:10525\u201310530","journal-title":"Proc Natl Acad Sci USA"},{"key":"107_CR20","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1161\/CIRCULATIONAHA.109.855114","volume":"120","author":"B Maurer","year":"2009","unstructured":"Maurer B, Busch N, J\u00fcngel A, Pileckyte M, Gay RE, Michel BA, Schett G, Gay S, Distler J, Distler O (2009) Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis. Circulation 120:2367\u20132376","journal-title":"Circulation"},{"key":"107_CR21","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/annrheumdis-2011-200940","volume":"71","author":"B Maurer","year":"2012","unstructured":"Maurer B, Reich N, Juengel A, Kriegsmann J, Gay RE, Schett G, Michel BA, Gay S, Distler JH, Distler O (2012) Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis. Ann Rheum Dis 71:1382\u20131387","journal-title":"Ann Rheum Dis"},{"key":"107_CR22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/MCB.01278-08","volume":"29","author":"Y Asano","year":"2009","unstructured":"Asano Y, Markiewicz M, Kubo M, Szalai G, Watson DK, Trojanowska M (2009) Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin. Mol Cell Biol 29:425\u2013434","journal-title":"Mol Cell Biol"},{"key":"107_CR23","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2353\/ajpath.2010.090593","volume":"176","author":"Y Asano","year":"2010","unstructured":"Asano Y, Stawski L, Hant F, Highland K, Silver R, Szalai G, Watson DK, Trojanowska M (2010) Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. Am J Pathol 176:1983\u20131998","journal-title":"Am J Pathol"},{"key":"107_CR24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrrheum.2014.128","volume":"10","author":"JC Broen","year":"2014","unstructured":"Broen JC, Radstake TR, Rossato M (2014) The role of genetics and epigenetics in the pathogenesis of systemic sclerosis. Nat Rev Rheumatol 10:671\u2013681","journal-title":"Nat Rev Rheumatol"},{"key":"107_CR25","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/art.11173","volume":"48","author":"C Feghali-Bostwick","year":"2003","unstructured":"Feghali-Bostwick C, Medsger TA, Wright TM (2003) Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum 48:1956\u20131963","journal-title":"Arthritis Rheum"},{"key":"107_CR26","author":"N Altorok","year":"2014","unstructured":"Altorok N, Almeshal N, Wang Y, Kahaleh B (2014) Epigenetics, the holy grail in the pathogenesis of systemic sclerosis. Rheumatology (Oxford). doi: 10.1093\/rheumatology\/keu155","journal-title":"Rheumatology (Oxford)"},{"key":"107_CR27","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.21948","volume":"54","author":"Y Wang","year":"2006","unstructured":"Wang Y, Fan PS, Kahaleh B (2006) Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum 54:2271\u20132279","journal-title":"Arthritis Rheum"},{"key":"107_CR28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/art.38948","volume":"67","author":"T Taniguchi","year":"2015","unstructured":"Taniguchi T, Asano Y, Akamata K, Noda S, Takahashi T, Ichimura Y, Toyama T, Trojanowska M, Sato S (2015) Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated fli-1-haploinsufficient mice. Arthritis Rheumatol 67:517\u2013526","journal-title":"Arthritis Rheumatol"},{"key":"107_CR29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1172\/JCI40295","volume":"120","author":"N Takeda","year":"2010","unstructured":"Takeda N, Manabe I, Uchino Y, Eguchi K, Matsumoto S, Nishimura S, Shindo T, Sano M, Otsu K, Snider P, Conway SJ, Nagai R (2010) Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest 120:254\u2013265","journal-title":"J Clin Invest"},{"key":"107_CR30","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1172\/JCI57582","volume":"121","author":"K Fujiu","year":"2011","unstructured":"Fujiu K, Manabe I, Nagai R (2011) Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J Clin Invest 121:3425\u20133441","journal-title":"J Clin Invest"},{"key":"107_CR31","doi-asserted-by":"crossref","first-page":"12319","DOI":"10.1073\/pnas.1635114100","volume":"100","author":"ML Whitfield","year":"2003","unstructured":"Whitfield ML, Finlay DR, Murray JI, Troyanskaya OG, Chi JT, Pergamenschikov A, McCalmont TH, Brown PO, Botstein D, Connolly MK (2003) Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci USA 100:12319\u201312324","journal-title":"Proc Natl Acad Sci USA"},{"key":"107_CR32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/jcp.20251","volume":"203","author":"S Chujo","year":"2005","unstructured":"Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, Takigawa M, Takehara K (2005) Connective tissue growth factor causes persistent pro\u03b12(I) collagen gene expression induced by transforming growth factor-\u03b2 in a mouse fibrosis model. J Cell Physiol 203:447\u2013456","journal-title":"J Cell Physiol"},{"key":"107_CR33","first-page":"115","volume":"1","author":"A Leask","year":"2009","unstructured":"Leask A (2009) Signaling in fibrosis: targeting the TGF\u03b2, endothelin-1 and CCN2 axis in scleroderma. Front Biosci (Elite Ed) 1:115\u2013122","journal-title":"Front Biosci (Elite Ed)"},{"key":"107_CR34","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1128\/MCB.01320-08","volume":"29","author":"Y Asano","year":"2009","unstructured":"Asano Y, Trojanowska M (2009) Phosphorylation of Fli1 at threonine 312 by protein kinase C \u03b4 promotes its interaction with p300\/CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor \u03b2. Mol Cell Biol 29:1882\u20131894","journal-title":"Mol Cell Biol"},{"key":"107_CR35","doi-asserted-by":"crossref","first-page":"34672","DOI":"10.1074\/jbc.M703907200","volume":"282","author":"Y Asano","year":"2007","unstructured":"Asano Y, Czuwara J, Trojanowska M (2007) Transforming growth factor-\u03b2 regulates DNA binding activity of transcription factor Fli1 by p300\/CREB-binding protein-associated factor-dependent acetylation. J Biol Chem 282:34672\u201334683","journal-title":"J Biol Chem"},{"key":"107_CR36","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9440(10)63685-1","volume":"163","author":"M Kubo","year":"2003","unstructured":"Kubo M, Czuwara-Ladykowska J, Moussa O, Markiewicz M, Smith E, Silver RM, Jablonska S, Blaszczyk M, Watson DK, Trojanowska M (2003) Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. Am J Pathol 163:571\u2013581","journal-title":"Am J Pathol"},{"key":"107_CR37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/1523-1747.ep12462561","volume":"90","author":"JS Perlish","year":"1988","unstructured":"Perlish JS, Lemlich G, Fleischmajer R (1988) Identification of collagen fibrils in scleroderma skin. J Invest Dermatol 90:48\u201354","journal-title":"J Invest Dermatol"},{"key":"107_CR38","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/01.bor.0000179945.73518.28","volume":"17","author":"M Fujimoto","year":"2005","unstructured":"Fujimoto M, Sato S (2005) B lymphocytes and systemic sclerosis. Curr Opin Rheumatol 17:746\u2013751","journal-title":"Curr Opin Rheumatol"},{"key":"107_CR39","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/art.22847","volume":"56","author":"R Lafyatis","year":"2007","unstructured":"Lafyatis R, O\u2019Hara C, Feghali-Bostwick CA, Matteson E (2007) B cell infiltration in systemic sclerosis-associated interstitial lung disease. Arthritis Rheum 56:3167\u20133168","journal-title":"Arthritis Rheum"},{"key":"107_CR40","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/annrheumdis-2011-200955","volume":"71","author":"K Khan","year":"2012","unstructured":"Khan K, Xu S, Nihtyanova S, Derrett-Smith E, Abraham D, Denton CP, Ong VH (2012) Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis. Ann Rheum Dis 71:1235\u20131242","journal-title":"Ann Rheum Dis"},{"key":"107_CR41","first-page":"291","volume":"23","author":"R Giacomelli","year":"1996","unstructured":"Giacomelli R, Cipriani P, Danese C, Pizzuto F, Lattanzio R, Parzanese I, Passacantando A, Perego MA, Tonietti G (1996) Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor \u03b21. J Rheumatol 23:291\u2013296","journal-title":"J Rheumatol"},{"key":"107_CR42","doi-asserted-by":"crossref","unstructured":"Jordan S, Distler JH, Maurer B, Huscher D, van Laar JM, Allanore Y, Distler O, on behalf of the EUSTAR Rituximab study group. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2013-204522","DOI":"10.1136\/annrheumdis-2013-204522"},{"key":"107_CR43","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/1346-8138.12461","volume":"41","author":"H Sumida","year":"2014","unstructured":"Sumida H, Asano Y, Tamaki Z, Aozasa N, Taniguchi T, Takahashi T, Toyama T, Ichimura Y, Noda S, Akamata K, Miyazaki M, Kuwano Y, Yanaba K, Sato S (2014) Successful experience of rituximab therapy for systemic sclerosis-associated interstitial lung disease with concomitant systemic lupus erythematosus. J Dermatol 41:418\u2013420","journal-title":"J Dermatol"}],"container-title":["Medical Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-015-0107-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00795-015-0107-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00795-015-0107-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:47:53Z","timestamp":1559112473000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00795-015-0107-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,19]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["107"],"URL":"https:\/\/doi.org\/10.1007\/s00795-015-0107-2","relation":{},"ISSN":["1860-1480","1860-1499"],"issn-type":[{"value":"1860-1480","type":"print"},{"value":"1860-1499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,19]]}}}